EDIT

#3045
Editas Medicine, Inc. Common Stock
2.20
+5.26%
版块:
基础:
利润货币:
日范围
2.20
2.20
年范围
0.91
4.54
日变化
+5.26%
每月变动
+3.29%
6个月变化
-18.52%
年变化
+22.91%
前一天收盘价
2.09
Open
2.20
Bid
Ask
Low
2.20
High
2.20
交易量
56
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
  • Market Capitalization 188.93 M
  • Employee 226
  • Founded N/A
  • CEO N/A
  • Website www.editasmedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG005MX5GZ2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.48
Price to sales ratio
6.26
Dividends per share
—
Dividend yield %
—

Editas Medicine Inc

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

新闻